title: Breast cancer subtypes: response to radiotherapy and potential radiosensitisation.
abstract: Radiotherapy (RT) is of critical importance in the locoregional management of early breast cancer. Over 50% of patients receive RT at some time during the treatment of their disease, equating to over 500 000 patients worldwide receiving RT each year. Unfortunately, not all patients derive therapeutic benefit and some breast cancers are resistant to treatment, as evidenced by distant metastatic spread and local recurrence. Prediction of individual responses to RT may allow a stratified approach to this treatment permitting those patients with radioresistant tumours to receive higher doses of RT (total and/or tumour cavity boost doses) and/or radiosensitising agents to optimise treatment. Also, for those patients unlikely to respond at all, it would prevent harmful side effects occurring for no therapeutic gain. More selective targeting would better direct National Health Service resources, ease the burden on heavily used treatment RT machines and reduce the economic cost of cancer treatment. Unfortunately, there are no robust and validated biomarkers for predicting RT outcome. We review the available literature to determine whether classification of breast cancers according to their molecular profile may be used to predict successful response to, or increased morbidity from, RT. Class-specific biomarkers for targeting by radiosensitising agents are also discussed.
authors: Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds, UK.
authors: F E
authors: FE
authors: Langlands
authors: K
authors: K
authors: Horgan
authors: D D
authors: DD
authors: Dodwell
authors: L
authors: L
authors: Smith
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000145:classification / Q000235:genetics / Q000532:radiotherapy*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D008207:Lymphatic Metastasis; D018579:Patient Selection; D011832:Radiation Injuries / Q000209:etiology; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D005819:Genetic Markers; D011838:Radiation-Sensitizing Agents
references: AJR Am J Roentgenol. 1992 Dec;159(6):1157-64
references: 1442375
references: Int J Cancer. 2008 Jul 1;123(1):236-40
references: 18398844
references: Cancer. 2000 May 15;88(10):2260-6
references: 10820347
references: Breast Cancer Res Treat. 2007 Nov;106(1):143-50
references: 17221151
references: Breast Cancer Res Treat. 2010 Feb;119(3):537-45
references: 19876731
references: Invest New Drugs. 2012 Dec;30(6):2113-20
references: 22127459
references: Int J Surg Pathol. 2005 Oct;13(4):319-27
references: 16273187
references: Clin Drug Investig. 2009;29(1):65-71
references: 19067476
references: Neoplasia. 2009 Nov;11(11):1194-207
references: 19881955
references: JAMA. 2006 Jun 7;295(21):2492-502
references: 16757721
references: J Clin Oncol. 2008 Mar 20;26(9):1419-26
references: 18285604
references: Breast Cancer Res. 2007;9(6):404; author reply 405
references: 18279542
references: Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10393-8
references: 12917485
references: Radiother Oncol. 2007 Jun;83(3):238-48
references: 17502118
references: Breast Cancer Res Treat. 2011 Nov;130(2):489-98
references: 21837481
references: Int J Cancer. 2001 Jul 15;93(2):172-8
references: 11410862
references: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
references: 12829800
references: J Clin Oncol. 2008 Aug 1;26(22):3785-90
references: 18591545
references: Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1460-7
references: 17931797
references: Clin Cancer Res. 2009 Jan 15;15(2):701-7
references: 19147777
references: Clin Cancer Res. 2007 May 15;13(10):2890-6
references: 17504988
references: Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1381-8
references: 16757130
references: N Engl J Med. 2009 Jul 9;361(2):123-34
references: 19553641
references: Eur J Cancer. 1995 Dec;31A(13-14):2185-90
references: 8652240
references: Clin Cancer Res. 2011 Mar 1;17(5):1082-9
references: 21233401
references: Clin Cancer Res. 2009 Nov 1;15(21):6619-29
references: 19843666
references: Lancet Oncol. 2010 Jan;11(1):21-8
references: 19897418
references: Nature. 2000 Aug 17;406(6797):747-52
references: 10963602
references: J Clin Oncol. 2009 Mar 1;27(7):1100-7
references: 19171712
references: Int J Radiat Biol. 2003 Jul;79(7):569-76
references: 14530152
references: Breast Cancer Res. 2010;12(2):R18
references: 20211017
references: J Natl Cancer Inst. 2001 Jul 4;93(13):979-89
references: 11438563
references: Clin Cancer Res. 2004 Aug 15;10(16):5367-74
references: 15328174
references: Oncologist. 2002;7 Suppl 4:2-8
references: 12202782
references: Ann Oncol. 2002 Jan;13(1):65-72
references: 11863114
references: Clin Cancer Res. 2000 Jun;6(6):2166-74
references: 10873065
references: Radiother Oncol. 2011 Aug;100(2):308-13
references: 21641069
references: Br J Cancer. 2001 Jan;84(2):164-9
references: 11161371
references: Lancet. 2005 Dec 17;366(9503):2087-106
references: 16360786
references: Cancer Res. 1999 Mar 15;59(6):1347-55
references: 10096569
references: J Natl Cancer Inst. 1992 May 6;84(9):683-9
references: 1314910
references: Clin Breast Cancer. 2009 Jun;9 Suppl 2:S73-81
references: 19596646
references: Clin Cancer Res. 2008 Dec 15;14(24):8010-8
references: 19088017
references: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):10-8
references: 17189062
references: Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):42-9
references: 20004525
references: J Clin Oncol. 2008 May 10;26(14):2373-8
references: 18413639
references: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references: 11553815
references: Urol Oncol. 2007 Mar-Apr;25(2):97-100
references: 17349522
references: N Engl J Med. 1995 Nov 30;333(22):1444-55
references: 7477144
references: J Clin Oncol. 2005 Oct 10;23(29):7350-60
references: 16145060
references: Biochemistry. 2000 Jun 27;39(25):7559-69
references: 10858306
references: Radiother Oncol. 2007 Mar;82(3):247-53
references: 17306393
references: Radiat Res. 1993 Aug;135(2):234-43
references: 8367595
references: Clin Cancer Res. 2008 Jan 1;14(1):14-24
references: 18172247
references: Nature. 2012 Apr 18;486(7403):346-52
references: 22522925